These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23278133)

  • 21. Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers.
    Cersosimo MG; Benarroch EE
    J Neurol Sci; 2012 Feb; 313(1-2):57-63. PubMed ID: 22001247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rotenone and elevated extracellular potassium concentration induce cell-specific fibrillation of α-synuclein in axons of cholinergic enteric neurons in the guinea-pig ileum.
    Sharrad DF; Chen BN; Gai WP; Vaikath N; El-Agnaf OM; Brookes SJ
    Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27997067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Embryonic stem cell-derived neuron models of Parkinson's disease exhibit delayed neuronal death.
    Yamashita H; Nakamura T; Takahashi T; Nagano Y; Hiji M; Hirabayashi T; Amano T; Yagi T; Sakai N; Kohriyama T; Matsumoto M
    J Neurochem; 2006 Jul; 98(1):45-56. PubMed ID: 16805795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. α-synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson's disease.
    Chu Y; Mickiewicz AL; Kordower JH
    Neurobiol Dis; 2011 Jan; 41(1):71-82. PubMed ID: 20816781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new perspective in Parkinson's disease, chaperone-mediated autophagy.
    Li B; Zhang Y; Yuan Y; Chen N
    Parkinsonism Relat Disord; 2011 May; 17(4):231-5. PubMed ID: 21215675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
    O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice.
    Pan-Montojo F; Schwarz M; Winkler C; Arnhold M; O'Sullivan GA; Pal A; Said J; Marsico G; Verbavatz JM; Rodrigo-Angulo M; Gille G; Funk RH; Reichmann H
    Sci Rep; 2012; 2():898. PubMed ID: 23205266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synucleins and their relationship to Parkinson's disease.
    von Bohlen Und Halbach O
    Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease.
    Lee SJ
    J Mol Neurosci; 2008; 34(1):17-22. PubMed ID: 18157654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
    Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ
    Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression pattern and localization of alpha-synuclein in the human enteric nervous system.
    Böttner M; Zorenkov D; Hellwig I; Barrenschee M; Harde J; Fricke T; Deuschl G; Egberts JH; Becker T; Fritscher-Ravens A; Arlt A; Wedel T
    Neurobiol Dis; 2012 Dec; 48(3):474-80. PubMed ID: 22850485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-synuclein is associated with the synaptic vesicle apparatus in the human and rat enteric nervous system.
    Böttner M; Fricke T; Müller M; Barrenschee M; Deuschl G; Schneider SA; Egberts JH; Becker T; Fritscher-Ravens A; Ellrichmann M; Schulz-Schaeffer WJ; Wedel T
    Brain Res; 2015 Jul; 1614():51-9. PubMed ID: 25896939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
    Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease.
    Gold A; Turkalp ZT; Munoz DG
    Mov Disord; 2013 Feb; 28(2):237-40. PubMed ID: 23362176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular neurosin degrades α-synuclein in cultured cells.
    Tatebe H; Watanabe Y; Kasai T; Mizuno T; Nakagawa M; Tanaka M; Tokuda T
    Neurosci Res; 2010 Aug; 67(4):341-6. PubMed ID: 20403393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity.
    Kontopoulos E; Parvin JD; Feany MB
    Hum Mol Genet; 2006 Oct; 15(20):3012-23. PubMed ID: 16959795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.